Arabic Arabic English English French French German German
dark

Cocrystal Pharma Reports First Quarter 2021 Financial Results and Provides Business Update

Cocrystal Pharma, Inc.  (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, reports financial results for the three months ended March 31, 2021 and provides updates on its antiviral pipeline and business activities.   Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Steps to Follow for Getting Your Hair Back to Its Former Self

Next Post

New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General Ward

Related Posts
Total
0
Share